bluuebunny/crossref_metadata_2025_split huggingface dataset:
CuCo and sulfur doped carbon nitride composite as an effective Fenton-like catalyst in a wide pH range
Authors: Lin Feifei , Liu Peng , Lin Rundong , Lu Chen , Shen Yuanyuan , Wang Yongqiang , Su Xiwen , Li Hongjiang , Gu Ying-Ying 
Published: August 2022

The heterogeneous Fenton-like reaction, as an advanced oxidation process, is widely recognized attributed to its recyclability, wide pH response range, easy solid-liquid separation, and non-production of iron sludge. Recently, the bimetallic catalysts have attracted intense attention due to their high catalytic performance and excellent stability over a wide pH range. In this article, CuCo/SCN bimetallic catalyst was prepared by pyrolysis method with sulfur doped carbon nitride (SCN) as the carrier. Under the conditions of pH = 7, catalyst dosage of 0.8 g/L, and concentration of H2O2 of 15 mM, 20 mg/L of methyl orange (MO) can be completely removed within 1 h. With the synergistic action between bimetals and sulfur doped carbon nitride, the CuCO/SCN involved Fenton-like system exhibited excellent catalytic degradation efficiency and strong stability for MO in neutral and weak alkaline conditions. The EPR characterization proved that OH and O2− were the main active components. Furthermore, CuCo/SCN involved Fenton-like system has good adaptability. Bimetallic CuCo/SCN catalyst has great application potential in the degradation of environmental pollutants.
Fluoxetine induces photochemistry-derived oxidative stress on Ulva lactuca
Authors: Feijão Eduardo , Cruz de Carvalho Ricardo , Duarte Irina A. , Matos Ana Rita , Cabrita Maria Teresa , Utkin Andrei B. , Caçador Isabel , Marques João Carlos , Novais Sara C. , Lemos Marco F. L. , Reis-Santos Patrick , Fonseca Vanessa F. , Duarte Bernardo 
Published: August 2022

Emerging pollutants impose a high degree of stress on marine ecosystems, compromising valuable resources, the planet and human health. Pharmaceutical residues often reach marine ecosystems, and their input is directly related to human activities. Fluoxetine is an antidepressant, and one of the most prescribed selective serotonin reuptake inhibitors globally and has been detected in aquatic ecosystems in concentrations up to 40 μg L−1. The present study aims to evaluate the impact of fluoxetine ecotoxicity on the photochemistry, energy metabolism and enzyme activity of Ulva lactuca exposed to environmentally relevant concentrations (0.3, 0.6, 20, 40, and 80 μg L−1). Exogenous fluoxetine exposure induced negative impacts on U. lactuca photochemistry, namely on photosystem II antennae grouping and energy fluxes. These impacts included increased oxidative stress and elevated enzymatic activity of ascorbate peroxidase and glutathione reductase. Lipid content increased and the altered levels of key fatty acids such as hexadecadienoic (C16:2) and linoleic (C18:2) acids revealed strong correlations with fluoxetine concentrations tested. Multivariate analyses reinforced the oxidative stress and chlorophyll a fluorescence-derived traits as efficient biomarkers for future toxicology studies.
Warming lake surface water temperatures in Lake Qiandaohu, China: Spatiotemporal variations, influencing factors and implications for the thermal structure
Authors: Li Yuan , Shi Kun , Zhang Yunlin , Zhu Guangwei , Guo Yulong , Li Huiyun , Du Chenggong 
Published: August 2022

Long-term lake surface water temperature (LSWT) products are valuable for understanding the responses of lake ecosystems to climate warming and for proposing suitable policies to protect lake ecosystems. Here, using Landsat satellite data and various in situ data, we documented 36 years (1986–2021) of spatiotemporal variations in LSWT in Lake Qiandaohu, a subtropical deep-water lake in China, and explored the potential driving factors of these variations. We validated the performances of the practical single-channel (PSC) algorithm, the generalized single-channel algorithm and the Landsat Level 2 land surface temperature product on Lake Qiandaohu with long-term in situ buoy data. Overall, the PSC algorithm had the best performance, with a mean absolute percent error (MAPE) of 7.5% and root mean square difference (RMSE) of 1.7°C. With 36 years of Landsat data and the PSC algorithm, the spatiotemporal variations in LSWT were constructed. The Landsat-derived 36-year mean LSWT in Lake Qiandaohu ranged from 18.2 to 23.1°C, with a mean value of 20.2°C. The northeast and southwest subsegments had the minimum (19.7°C) and maximum (20.6°C) mean LSWT values, respectively. The spatial variations in LSWT could be explained in part by the water depth. From 1986 to 2021, a significant warming trend was observed in Lake Qiandaohu, with a warming rate of 0.07°C/year. The warming rate of Lake Qiandaohu was faster than that of the local air temperature (warming rate = 0.04°C/year). The LSWT warming in Lake Qiandaohu can mainly be attributed to the warming air temperatures. Lake warming has increased the thermal stability in Lake Qiandaohu and has had negative impact on the lake ecosystem. Our work highlights the importance of using satellite data to understand the responses of lake ecosystems to climate change.
Expression of lactate-related signatures correlates with immunosuppressive microenvironment and prognostic prediction in ewing sarcoma
Authors: Zhang Zhao , Pan Jingxin , Cheng Debin , Shi Yubo , Wang Lei , Mi Zhenzhou , Fu Jun , Tao Huiren , Fan Hongbin 
Published: August 2022

Objectives: Ewing sarcoma (EWS) is an aggressive tumor of bone and soft tissue. Growing evidence indicated lactate as a pivotal mediator of crosstalk between tumor energy metabolism and microenvironmental regulation. However, the contribution of lactate-related genes (LRGs) in EWS is still unclear.Methods: We obtained the transcriptional data of EWS patients from the GEO database and identified differentially expressed-LRGs (DE-LRGs) between EWS patient samples and normal tissues. Unsupervised cluster analysis was utilized to recognize lactate modulation patterns based on the expression profile of DE-LRGs. Functional enrichment including GSEA and GSVA analysis was conducted to identify molecular signaling enriched in different subtypes. ESTIMATE, MCP and CIBERSORT algorithm was used to explore tumor immune microenvironment (TIME) between subtypes with different lactate modulation patterns. Then, lactate prognostic risk signature was built via univariate, LASSO and multivariate Cox analysis. Finally, we performed qPCR analysis to validate candidate gene expression.Result: A total of 35 DE-LRGs were identified and functional enrichment analysis indicated that these LRGs were involved in mitochondrial function. Unsupervised cluster analysis divided EWS patients into two lactate modulation patterns and we revealed that patients with Cluster 1 pattern were linked to poor prognosis and high lactate secretion status. Moreover, TIME analysis indicated that the abundance of multiple immune infiltrating cells were dramatically elevated in Cluster 1 to Cluster 2, including CAFs, endothelial cells, Macrophages M2, etc., which might contribute to immunosuppressive microenvironment. We also noticed that expression of several immune checkpoint proteins were clearly increased in Cluster 1 to Cluster 2. Subsequently, seven genes were screened to construct LRGs prognostic signature and the performance of the resulting signature was validated in the validation cohort. Furthermore, a nomogram integrating LRGs signature and clinical characteristics was developed to predict effectively the 4, 6, and 8-year prognosis of EWS patients.Conclusion: Our study revealed the role of LRGs in immunosuppressive microenvironment and predicting prognosis in EWS and provided a robust tool to predict the prognosis of EWS patients.
Immunologic phenotype of patients with long-COVID syndrome of 1-year duration
Authors: García-Abellán Javier , Fernández Marta , Padilla Sergio , García José Alberto , Agulló Vanesa , Lozano Valle , Ena Nuria , García-Sánchez Lidia , Gutiérrez Félix , Masiá Mar 
Published: August 2022

BackgroundThe pathophysiology of long-COVID remains unknown, and information is particularly limited for symptoms of very long duration. We aimed to assess the serological, T-cell immune responses and ANA titers of patients with long-COVID-19 syndrome of 1-year duration.MethodsProspective, longitudinal study of hospitalized COVID-19 patients followed-up for 12 months. Sequential blood samples and COVID-19 symptom questionnaires (CSQ) were obtained, and humoral and cellular immune responses, antinuclear antibodies (ANA) and inflammation biomarkers were analyzed.ResultsOf 154 patients discharged from hospital, 72 non-vaccinated with available CSQ in all visits were included. Of them, 14 (19.4%) reported persistent symptoms both at 6-months and 12-months, mainly asthenia (15.3%), myalgia (13.9%), and difficulty concentrating/memory loss (13.9%). Symptomatic patients were more frequently women, smokers, showed higher WHO severity score, and a trend to higher ICU admission. In the adjusted analysis, long-COVID syndrome was associated with lower frequency of detectable neutralizing antibodies (adjusted hazard ratio [aHR] 0.98; 95% confidence interval [CI], 0.97-0.99) and lower SARS-CoV-2-S1/S2 titers (aHR [95%CI] 0.14 [0.03–0.65]). T-cell immune response measured with a SARS-CoV-2-interferon-γ release assay was not different between groups. There was a higher frequency of positive ANA titers (≥160) in symptomatic patients (57.1% vs 29.3%, p=0.04), that was attenuated after adjustment aHR [95% CI] 3.37 [0.84-13.57], p=0.087. Levels of C-reactive protein and D-dimer were higher during follow-up in symptomatic patients, but with no differences at 12 months.ConclusionPatients with 1-year duration long-COVID-19 syndrome exhibit a distinct immunologic phenotype that includes a poorer SARS-CoV-2 antibody response, low-degree chronic inflammation that tends to mitigate, and autoimmunity.
Facing the Omicron variant—how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review
Authors: Külper-Schiek Wiebe , Piechotta Vanessa , Pilic Antonia , Batke Madeleine , Dreveton Léa-Sophie , Geurts Brogan , Koch Judith , Köppe Stefan , Treskova Marina , Vygen-Bonnet Sabine , Waize Maria , Wichmann Ole , Harder Thomas 
Published: August 2022

BackgroundThe severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variant is currently the dominant variant globally. This third interim analysis of a living systematic review summarizes evidence on the effectiveness of the coronavirus disease 2019 (COVID-19) vaccine (vaccine effectiveness, VE) and duration of protection against Omicron.MethodsWe systematically searched literature on COVID-19 for controlled studies, evaluating the effectiveness of COVID-19 vaccines approved in the European Union up to 14/01/2022, complemented by hand searches of websites and metasearch engines up to 11/02/2022. We considered the following comparisons: full primary immunization vs. no vaccination, booster immunization vs. no vaccination, and booster vs. full primary immunization. VE against any confirmed SARS-CoV-2 infection, symptomatic, and severe COVID-19 (i.e., COVID-19-related hospitalization, ICU admission, or death) was indicated, providing estimate ranges. Meta-analysis was not performed due to high study heterogeneity. The risk of bias was assessed with ROBINS-I, and the certainty of the evidence was evaluated using GRADE.ResultsWe identified 26 studies, including 430 to 2.2 million participants, which evaluated VE estimates against infections with the SARS-CoV-2 Omicron variant. VE against any confirmed SARS-CoV-2 infection ranged between 0–62% after full primary immunization and between 34–66% after a booster dose compared to no vaccination. VE range for booster vs. full primary immunization was 34–54.6%. After full primary immunization VE against symptomatic COVID-19 ranged between 6-76%. After booster immunization VE ranged between 3-84% compared to no vaccination and between 56-69% compared to full primary immunization. VE against severe COVID-19 ranged between 3-84% after full primary immunization and between 12-100% after booster immunization compared to no vaccination, and 100% (95% CI 71.4-100) compared to full primary immunization (data from only one study). VE was characterized by a moderate to strong decline within 3–6 months for SARS-CoV-2 infections and symptomatic COVID-19. Against severe COVID-19, protection remained robust for at least up to 6 months. Waning immunity was more profound after primary than booster immunization. The risk of bias was moderate to critical across studies and outcomes. GRADE certainty was very low for all outcomes.ConclusionsUnder the Omicron variant, the effectiveness of EU-licensed COVID-19 vaccines in preventing any SARS-CoV-2 infection is low and only short-lasting after full primary immunization, but can be improved by booster vaccination. VE against severe COVID-19 remains high and is long-lasting, especially after receiving the booster vaccination.
Serum peptidome profiles immune response of COVID-19 Vaccine administration
Authors: Zhang Wenjia , Li Dandan , Xu Bin , Xu Lanlan , Lyu Qian , Liu Xiangyi , Li Zhijie , Zhang Jian , Sun Wei , Ma Qingwei , Qiao Liang , Liao Pu 
Published: August 2022

BackgroundCoronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused significant loss of life and property. In response to the serious pandemic, recently developed vaccines against SARS-CoV-2 have been administrated to the public. Nevertheless, the research on human immunization response against COVID-19 vaccines is insufficient. Although much information associated with vaccine efficacy, safety and immunogenicity has been reported by pharmaceutical companies based on laboratory studies and clinical trials, vaccine evaluation needs to be extended further to better understand the effect of COVID-19 vaccines on human beings.MethodsWe performed a comparative peptidome analysis on serum samples from 95 participants collected at four time points before and after receiving CoronaVac. The collected serum samples were analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) to profile the serum peptides, and also subjected to humoral and cellular immune response analyses to obtain typical immunogenicity information.ResultsSignificant difference in serum peptidome profiles by MALDI-TOF MS was observed after vaccination. By supervised statistical analysis, a total of 13 serum MALDI-TOF MS feature peaks were obtained on day 28 and day 42 of vaccination. The feature peaks were identified as component C1q receptor, CD59 glycoprotein, mannose-binding protein C, platelet basic protein, CD99 antigen, Leucine-rich alpha-2-glycoprotein, integral membrane protein 2B, platelet factor 4 and hemoglobin subunits. Combining with immunogenicity analysis, the study provided evidence for the humoral and cellular immune responses activated by CoronaVac. Furthermore, we found that it is possible to distinguish neutralizing antibody (NAbs)-positive from NAbs-negative individuals after complete vaccination using the serum peptidome profiles by MALDI-TOF MS together with machine learning methods, including random forest (RF), partial least squares-discriminant analysis (PLS-DA), linear support vector machine (SVM) and logistic regression (LR).ConclusionsThe study shows the promise of MALDI-TOF MS-based serum peptidome analysis for the assessment of immune responses activated by COVID-19 vaccination, and discovered a panel of serum peptides biomarkers for COVID-19 vaccination and for NAbs generation. The method developed in this study can help not only in the development of new vaccines, but also in the post-marketing evaluation of developed vaccines.
Assessment of the interactions between cetaceans and fisheries at the south of the Cetacean Migration Corridor and neighboring waters (Western Mediterranean)
Authors: Izquierdo-Serrano Mar , Revuelta Ohiana , Míguez-Lozano Raúl , Gozalbes Patricia , Ruiz-García David , Raga Juan Antonio , Tomás Jesús 
Published: August 2022

The Cetacean Migration Corridor is an important marine protected area for cetacean species in the Western Mediterranean, and part of its waters constitute the main fishing grounds for the Valencia region (East Spain) fishing fleet. Here we aim to assess the interactions between all active fisheries operating in the waters of the Valencia region and the cetacean species inhabiting this area. A total of 282 face-to-face interviews (51.37% of the total fleet) to fishers were held on 20 ports at the study area to gather information about cetacean by-catch and all types of interactions between fisheries and cetaceans. The interviewed bottom trawlers (n= 148 boats) reported a monthly by-catch rate (C) of 0.01 dolphins per vessel. Bottom trawling vessels operating at neritic zones only reported by-catch of common bottlenose dolphin (C= 0.009), while those fishing at oceanic zones by-caught striped dolphin (C= 0.006) and common bottlenose dolphin (C= 0.003). The interviewed artisanal fishers (n = 114 boats), the second most important fishery in the study area, only reported one dolphin by-catch event, but 90 of these boats communicated continued negative interactions with the common bottlenose dolphin, causing gear damage and catch take. The interviewed vessels gave an estimation of their annual economic loss produced by this interaction (mean ± SD: 2,998.10 ± 2095.02 € per boat). Other fisheries operating in the Valencia region were purse-seiners (n= 15 boats) and pelagic longlines, a fishery that has almost disappeared in the study area (n= 5 boats). The first one had the highest estimated dolphin by-catch rate (C= 0.04) and mainly interacted with common bottlenose dolphin, but also with striped dolphin. The information gathered from interviews was complimented with long-term stranding data (1990–2020). Despite the fact that only 7.80% of all recorded stranded cetaceans showed fisheries interaction signs, 26.72% of the common bottlenose dolphins recorded showed evidence of this interaction, thus confirming that it is the cetacean species most affected by fisheries in the area. Records of stranded striped dolphin (6.45%) also showed evidence of fisheries interaction. Based on both dolphin by-catch and gear damage, management plans are needed in the area to ensure cetacean conservation and also fisheries sustainability in waters inside and around marine protected areas at the Spain’s Mediterranean.
Identification of N7-methylguanosine related signature for prognosis and immunotherapy efficacy prediction in lung adenocarcinoma
Authors: Li Zhouhua , Wang Wenjun , Wu Juan , Ye Xiaoqun 
Published: August 2022

BackgroundLung adenocarcinoma (LUAD) is one of the most frequent causes of tumor-related mortality worldwide. Recently, the role of N7-methylguanosine (m7G) in tumors has begun to receive attention, but no investigation on the impact of m7G on LUAD. This study aims to elucidate the significance of m7G on the prognosis and immunotherapy in LUAD.MethodsConsensus clustering was employed to determine the molecular subtype according to m7G-related regulators extracted from The Cancer Genome Atlas (TCGA) database. Survival, clinicopathological features and tumor mutational burden (TMB) analysis were applied to research molecular characteristics of each subtype. Subsequently, “limma” package was used to screen differentially expressed genes (DEGs) between subtypes. In the TCGA train cohort (n = 245), a prognostic signature was established by univariate Cox regression, lasso regression and multivariate Cox regression analysis according to DEGs and survival analysis was employed to assess the prognosis. Then the prognostic value of the signature was verified by TCGA test cohort (n = 245), TCGA entire cohort (n = 490) and GSE31210 cohort (n = 226). Moreover, the association among immune infiltration, clinical features and the signature was investigated. The immune checkpoints, TMB and tumor immune dysfunction and exclusion (TIDE) were applied to predict the immunotherapy response.ResultsTwo novel molecular subtypes (C1 and C2) of LUAD were identified. Compared to C2 subtype, C1 subtype had poorer prognosis and higher TMB. Subsequently, the signature (called the “m7G score”) was constructed according to four key genes (E2F7, FAM83A, PITX3, and HOXA13). The distribution of m7G score were significantly different between two molecular subtypes. The patients with lower m7G score had better prognosis in TCGA train cohort and three verification cohort. The m7G score was intensively related to immune infiltration. Compared with the lower score, the higher m7G score was related to remarkable upregulation of the PD-1 and PD-L1, the higher TMB and the lower TIDE score.ConclusionThis study established a m7G-related signature for predicting prognosis and immunotherapy in LUAD, which may contribute to the development of new therapeutic strategies for LUAD.
Severe lupus nephritis in the present days
Authors: Moroni Gabriella , Calatroni Marta , Ponticelli Claudio 
Published: August 2022

Lupus nephritis (LN) is one of the most frequent and severe organ manifestations of systemic lupus erythematosus (SLE) that is a chronic autoimmune disease. Despite improvement in patient and renal prognosis, the disease continued to be associated with a high rate of end stage kidney disease. Along the last decades, it seems that the epidemiology of LN and its clinical presentation have progressively changed. The forms with renal insufficiency at presentation seem to have progressively reduced in developed countries in favour of more mild clinical presentations with urinary abnormalities only. To this clinical change does not correspond a less severe histological lesions, in fact, the extent of active lesions at kidney biopsy are unchanged, whereas chronic lesions are becoming less frequent and less severe. Meanwhile, new types of severe LN defined by the variable association of demographic, clinical, histological characteristics at diagnosis or during the follow-up are gradually emerging and require attention in assessing the therapy and prognosis.During the last years, randomized controlled trials have reported the efficacy of new drugs in association with standard therapy to improve the rate of short- and medium-term renal response. One of the advantages is that these results were obtained with reduced dosage of corticosteroids whose protracted use is associated with increase of chronic organ damage. Optimization of therapeutical strategies, tailored on the demographic clinical and histological characteristics, with combination of old and new drugs are urgently needed for severe LN.